Last reviewed · How we verify
NCT00136136
Validation of Bispectral Index (BIS)-Monitor in 3 Groups of Newborn Children
trial testing Registration of the bispectral index and spectral edge frequency in Behavior in 24 participants. Completed in 31 December 2004.
31 December 2004
Quick facts
| Lead sponsor | University Hospital, Ghent |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 24 |
| Start date | 1 August 2003 |
| Primary completion | 31 December 2004 |
| Estimated completion | 31 December 2004 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- Registration of the bispectral index and spectral edge frequency
Conditions studied
- Behavior — all drugs for Behavior →
Sponsor
University Hospital, Ghent
Who can join
1 Minute and older, any sex, with Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will evaluate the registration of the bispectral index and spectral edge frequency in relation to the behavioural state.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT00136136
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Behavior
Currently open trials in the same condition.
- NCT07373626 — Physical Activity Trends in Cancer Survivors Treated at the 'MOvement and REhabilitation' Clinic · recruiting
- NCT06908447 — Cold Water and Decision-Making · NA · recruiting
- NCT07133529 — Decision-making and Food Intake · NA · recruiting
- NCT06862193 — Effectiveness of Digital Intervention (HM4MH-app) on Perinatal Psychological Wellbeing · NA · recruiting
- NCT06593613 — Pilot Trial of the RUBI Program for Autistic Adults · NA · recruiting
Other University Hospital, Ghent trials
Trials by the same sponsor.
- NCT07584486 — Development of a New Simplified Tool to Predict LNPCPs Histology and Assess the Risk of Submucosal Invasive Cancer. The · NA · not yet recruiting
- NCT07327450 — Coaching Doctors and Nurses to Improve Ethical Decision-making in Team · NA · not yet recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07387328 — Validation of New sEMG Electrode Placement Guidelines for the Triceps Surae in Post-stroke Individuals. · not yet recruiting
- NCT07237399 — Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00136136 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Ghent
- Last refreshed: 22 December 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00136136.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing